Strut Health review

A convenient format does not settle the medicine choice

Strut belongs on a compounded-care shortlist only after the product question has been answered. Its semaglutide page offers a weekly injection and a daily buccal lozenge, with consultations and shipping included. ^[1] That creates a straightforward-looking purchase. The important catch is that a lozenge and a branded injectable are different preparations. If the main attraction is avoiding needles, start by asking which approved formulations are appropriate before treating the lozenge as an interchangeable route to the same clinical result.

Read the advertised amount as a particular offer

Strut advertises $129 for a monthly injectable semaglutide vial and $199 for a 30-day buccal-lozenge supply, including physician consultations and shipping. Final pricing follows consultation. ^[1] Those figures do not establish one complete recurring total for every patient. Obtain the quantity supplied, treatment interval, intended formulation and amount due at renewal together. A vial count is not a duration unless the prescribed directions make that duration clear. Do not select a longer purchase simply because its monthly equivalent looks smaller; flexibility has value when a clinician may change the plan.

Also establish what happens if the treatment is not appropriate, you cannot tolerate it or the prescription changes before the next shipment. Those are different events and can have different financial consequences. The useful price is the charge for the treatment you can actually receive, with its cancellation deadline attached.

Keep the written quote available when the next refill is reviewed so a changed charge can be explained.

The warning letter belongs in the decision

On February 20, 2026, FDA warned Strut about misleading compounded-drug advertising, including representations about the compounder and implications of approval. ^[2] The letter is dated evidence of a regulatory concern; it does not establish the current disposition of every product or a later corrective-action outcome. That distinction matters. Buyers should seek a clear current explanation of who prepares the proposed prescription rather than infer a manufacturer from a website photograph.

Compounded drugs are not FDA-approved. ^[3] A platform, a prescriber and a dispensing pharmacy do different jobs. Identify all three on the actual treatment documents. A short online assessment can be convenient, but convenience cannot establish product quality or determine whether compounding is justified for an individual.

To understand the evidence behind this part of the decision, read our Oral vs injectable GLP-1 treatment in 2026. The guide distinguishes a study result from the service being purchased.

What follow-up needs to cover

Messaging is useful when the person receiving the message can address the issue. Establish how prescribing questions reach the clinician, how refill changes are handled and where urgent symptoms belong. A customer-service reply about shipping is a different service from medical advice. For someone new to treatment, that distinction may matter more than whether the first box arrives quickly. Keep a copy of the directions attached to the dispensed preparation; a change of vial or concentration should prompt fresh confirmation from the care team.

Choose the pathway before the subscription

Compare Ro if your priority is help pursuing branded medication through insurance. Compare Form Health if the missing piece is a continuing medical-and-nutrition relationship. Strut is more relevant when a clinician has explained a specific need for compounded treatment and the selected preparation is acceptable to you. Do not let the availability of a needle-free option turn that sequence around. A product-specific discussion, a written recurring quote and an understandable route to clinical follow-up should come before the payment decision.

For the next decision, use our Ro Body review to compare the kind of support you would actually use.

Understanding the cost

Advertised compounded semaglutide offers: $129 per monthly injectable vial or $199 per 30-day buccal-lozenge supply, including physician consultations and shipping. Final pricing follows consultation; a complete individual recurring total is not established.